Photomicrograph showing a Lewy body (center), a clump of misfolded alpha-synuclein proteins believed to be a factor in Parkinson’s disease. The inset shows the location of the substantia nigra, an area of the brain that influences movement and cognition, where this Lewy body was found. A Johns Hopkins Medicine team has developed an artificial enzyme that stops misfolded alpha-synuclein from spreading and may lead to a therapy for Parkinson’s. Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, using public domain images


Artificial enzyme may be first step toward treatment for parkinson’s disease


Leave A Reply